Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug;70(4):729-738.
doi: 10.1007/s12223-025-01287-z. Epub 2025 Jun 28.

Antimicrobial resistance mechanisms in non-tuberculous mycobacteria

Affiliations
Review

Antimicrobial resistance mechanisms in non-tuberculous mycobacteria

Esra Gül Tursun et al. Folia Microbiol (Praha). 2025 Aug.

Abstract

Non-tuberculous mycobacteria (NTM) are pathogens that are widely distributed in the environment and cause increasing rates of human infections. High levels of antimicrobial resistance shown by these bacteria complicate infection management and limit treatment options. The complex structure of cell walls and features such as biofilm formation are responsible for intrinsic resistance in NTMs. Antimicrobial resistance can be explained by four basic mechanisms: (i) limitation of drug uptake, meaning antibiotic entry is limited due to the presence of a hydrophobic and low permeability cell wall and a small number of porin channels, (ii) enzymatic modification of antibiotics, (iii) target site modification, (iv) efflux pumps, which prevent drug accumulation by actively expelling antibiotics from the cell and reduce treatment efficacy. For effective management of NTM infections, detailed understanding of resistance mechanisms, development of species-specific treatment protocols, and discovery of new antimicrobial agents are of great importance. In this review, the mechanisms causing drug resistance in NTMs will be reviewed.

Keywords: Antimicrobial resistance; Cell wall; Non-tuberculous mycobacteria; Resistance mechanism.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval: Not applicable. Competing interests: The authors declare no competing interests.

References

    1. Alav I, Sutton JM, Rahman KM (2018) Role of bacterial efflux pumps in biofilm formation. J Antimicrob Chemother 73:2003–2020. https://doi.org/10.1093/jac/dky042 - DOI - PubMed
    1. AlMatar M, Albarri O, Makky EA, Köksal F (2021) Efflux pump inhibitors: new updates. Pharmacol Rep 73:1–16. https://doi.org/10.1007/s43440-020-00160-9 - DOI - PubMed
    1. Broncano-Lavado A, Senhaji-Kacha A, Santamaría-Corral G, Esteban J, García-Quintanilla M (2022) Alternatives to antibiotics against Mycobacterium abscessus. Antibiot (Basel) 11(10):1322 https://doi.org/10.3390/antibiotics11101322
    1. Brown-Elliott Barbara A, Nash Kevin A, Wallace Richard J (2012) Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev 25:545–582. https://doi.org/10.1128/cmr.05030-11 - DOI - PubMed - PMC
    1. Brown-Elliott BA, Woods GL (2019) Antimycobacterial susceptibility testing of nontuberculous mycobacteria. J Clin Microbiol 57. https://doi.org/10.1128/jcm.00834-19

MeSH terms

LinkOut - more resources